Discovery of Adjuvants for mRNA Vaccines
NIAID - National Institute of Allergy and Infectious Diseases
About This Grant
The offeror’s proposed work plan aims to identify, characterize and optimize non-toxic, low molecular weight agents as adjuvants that a) enhance protein antigen accumulation and release in non-immune and immune cells after intramuscular administration of mRNA vaccine and b) stimulate innate immune pathway-activation in antigen presenting cells.
Grant Summary
Discovery of Adjuvants for mRNA Vaccines is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $1.3M for university, nonprofit, healthcare org. Applications are due 2026-09-29 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $1.3M
2026-09-29
- 1Confirm your organization is eligible for Discovery of Adjuvants for mRNA Vaccines from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Discovery of Adjuvants for mRNA Vaccines: Frequently Asked Questions
Who is eligible for the Discovery of Adjuvants for mRNA Vaccines?
Discovery of Adjuvants for mRNA Vaccines is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Discovery of Adjuvants for mRNA Vaccines provide?
Discovery of Adjuvants for mRNA Vaccines provides up to $1.3M per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Discovery of Adjuvants for mRNA Vaccines deadline?
Applications for Discovery of Adjuvants for mRNA Vaccines are due 2026-09-29 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Discovery of Adjuvants for mRNA Vaccines?
To apply for Discovery of Adjuvants for mRNA Vaccines, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.